With respect to AHR, the quinoline-3-carboxamide derivative and AHR ligand, paquinimod, inhibits fibrosis in murine models of experimental systemic sclerosis (Stenstrom et al., 2016) and liver fibrosis (Fransen Pettersson et al., 2018). Here, AHR is linked to Hepatic fibrosis.